ISRCTN38449870已完成未知
Polypharmacy - Reduction of Inappropriate Medication and Adverse drug events in older patients: a randomized controlled trial
Council of Health Service of the Autonomous Province of Bolzano ? South Tyrol (Italy)0 个研究点目标入组 622 人开始时间: 2013年9月30日最近更新:
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 622
研究概览
简要总结
2021 Results article in https://pubmed.ncbi.nlm.nih.gov/33743582/ (added 22/03/2021)
研究设计
- 研究类型
- Interventional
入排标准
- 性别
- All
入选标准
- •1. Aged over 74 years
- •2. Taking eight or more drugs
排除标准
- •1. Life expectancy assumed to be less than three months
- •2. Advanced cancer
- •3. Ongoing chemotherapy and/or therapeutic radiation
- •4. Severe dementia
- •5. Patients not able to give informed consent
研究者
相似试验
已完成
不适用
Improving medicines use in people who take multiple medicinesISRCTN90146150niversity of Bristol1,983
已完成
不适用
PRIMA-eDS: Polypharmacy in chronic diseases: Reduction of Inappropriate Medication and Adverse drug events in elderly populations by electronic Decision SupportISRCTN10137559Witten/Herdecke University (Universität Witten/Herdecke)3,904
已完成
不适用
Medication Regimen Complexity and Glycemic Control in Patients With DiabetesDiabetes MellitusNCT03324971Kasr El Aini Hospital78
尚未招募
不适用
Polypharmacy of antipsychotics in SchizophreniaCTRI/2021/04/033286Paul Mathew
已完成
不适用
The Prevention of Polypharmacy in Primary Care Patients Trial (4P-RCT)ISRCTN16560559Institute of Primary Care - University of Zurich (Institut für Hausarztmedizin der Universität Zürich) (Switzerland)334
